[28-19-am] Pharmacotherapy (Clinical Research) | The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)

Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[28-19-am]Pharmacotherapy (Clinical Research)

Fri. Mar 28, 2025 3:00 PM - 4:36 PM JST
Fri. Mar 28, 2025 6:00 AM - 7:36 AM UTC

Room 19 (FUKUOKA SUNPALACE: Palace RoomA [2F])

Chair: Kaname Ohyama, Marie Suehiro

3:00 PM - 3:12 PM JST(6:00 AM - 6:12 AM UTC)

[28-19-pm09S]PCV13 versus PCV15 and PPSV23/PCV13 versus PPSV23/PCV15 for the prevention of pneumococcal infections: a systematic review and meta-analysis

○Ayu Tsubouchi¹, Yuri Matsumoto¹, Takayuki Mihara¹, Shintaro Ikegami¹, Mishu Takahashi¹, Kanon Nakabayashi¹, Naoto Nishimoto¹, Yuki Mizukami¹, Takuma Muraishi¹, Yuki Enoki¹, Kazuaki Taguchi¹, Kazuaki Matsumoto¹ (1. Keio University)

3:12 PM - 3:24 PM JST(6:12 AM - 6:24 AM UTC)

[28-19-pm10S]Outcome of lithium discontinuation in lithium-induced nephrogenic diabetes insipidus based on the spontaneous adverse event reporting database VigiBase

○Kazuki Fukushima¹, Yuichi Tasaka¹, Hideki Nawa¹ (1. Sch. Pharm., Shujitsu Univ.)

3:24 PM - 3:36 PM JST(6:24 AM - 6:36 AM UTC)

[28-19-pm11S]Efficacy and safety of imeglimin in elderly patients with type 2 diabetes

○Kyoko Oiwa¹, Ayako Kato¹, Wataru Nihei¹, Tatsuya Muto², Koichi Kato¹ (1. Laboratory of Medicine, Aichi Gakuin University, School of Pharmacy, 2. Meitetsu Hospital Pharmacy)

3:36 PM - 3:48 PM JST(6:36 AM - 6:48 AM UTC)

[28-19-pm12]Maternal and Neonatal Clinical Outcomes of Antithrombotic Therapy in Pregnant Women with Valvular Heart Disease: A Retrospective Cohort Study

○Yuki Yanagisawa¹, Masami Tsuchiya¹, Shungo Imai¹, Hayato Kizaki¹, Satoko Hori¹ (1. Pharm. Sci., Keio Univ.)

3:48 PM - 4:00 PM JST(6:48 AM - 7:00 AM UTC)

[28-19-pm13S]Effect of estrogen suppressants on prescription frequency of topical corticosteroids in female patients: Evidence from outpatient prescription receipt data analysis.

○Shotaro Kurahashi^1,2, Tomoyoshi Miyamoto³, Maki Yamaguchi², Takashi Yamamoto^1,2, Mikio Sakakibara², Atsufumi Kawabata¹ (1. Fac. Pharm., Kindai Univ., 2. Sugi Pharmacy Co., Ltd., 3. Sch. Pharm., Hyogo Med. Univ.)

4:00 PM - 4:12 PM JST(7:00 AM - 7:12 AM UTC)

[28-19-pm14]Embolic event rates and bleeding event rates in non-valvular atrial fibrillation patients with low BMI
-Comparison of Warfarin and Edoxabantosilate-

○Mako Watanabe¹, Masanori Suzuki^2,4, Sayaka Izumi², Ryokan Funakoshi^2,3 (1. Postgraduate Education Center dept., Kameda Hosp., 2. Pharm. dept., Kameda Hosp., 3. Drugs Control dept., Kameda Hosp., 4. Pharm. Sci., Teikyo Heisei Univ.)

4:12 PM - 4:24 PM JST(7:12 AM - 7:24 AM UTC)

[28-19-pm15S]Population Pharmacokinetic-Pharmacodynamic Analysis of Triglyceride-Lowering Effects of Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin

○Ryosuke Terada¹, Shinji Kobuchi¹, Yukako Ito¹, Kenichiro Kato², Tetsuo Hayakawa², Toshiyuki Sakaeda¹ (1. Kyoto Pharm. Univ., 2. Tonami General Hosp. Diabetes/Endocrinology)

4:24 PM - 4:36 PM JST(7:24 AM - 7:36 AM UTC)

[28-19-pm16]Even as-needed NSAIDs may not reduce the risk of renal dysfunction in Triple Whammy.

○Mayu Shimura¹, Satoshi Nakagomi¹, Erika Omata¹, Jin Miyamoto¹, Miwako Kobayashi¹, Fumihiko Kitta¹, Takaaki Suzuki¹ (1. University of Yamanashi Hospital)

Back to Category List